The Lescol® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

Author： Serruys Patrick WJC   de Feyter Pim J   Benghozi Renée   Hugenholtz Paul G   Lesaffre Emmanuel  

Publisher： Informa Healthcare

ISSN： 1471-1796

Source： International Journal of Cardiovascular Interventions, Vol.4, Iss.4, 2001-12, pp. : 165-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled study

By  

ESC HEART FAILURE, Vol. 2, Iss. 1, 2015-03 ,pp. : 5-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Antidepressant Treatment with Moclobemide for Aphasia in Acute Stroke Patients: A Randomised, Double-Blind, Placebo-Controlled Study

By  

Cerebrovascular Diseases, Vol. 19, Iss. 2, 2005-02 ,pp. : 125-132

Karger

Access to resources Recommend Favorite

Effects of l-Acetylcarnitine on Cirrhotic Patients with Hepatic Coma: Randomized Double-Blind, Placebo-Controlled Trial

By Malaguarnera Mariano   Pistone Giovanni   Astuto Marinella   Vecchio Ignazio   Raffaele Rocco   Lo Giudice Emilia   Rampello Liborio  

Digestive Diseases and Sciences, Vol. 51, Iss. 12, 2006-12 ,pp. : 2242-2247

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Preoperative Gabapentin on Postoperative Nausea and Vomiting after Open Cholecystectomy: A Prospective Randomized Double-Blind Placebo-Controlled Study

By  

Medical Principles and Practice, Vol. 19, Iss. 1, 2009-12 ,pp. : 57-60

Karger

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke

By  

Cerebrovascular Diseases, Vol. 12, Iss. 3, 2001-10 ,pp. : 253-257

Karger

Access to resources Recommend Favorite